Medications for treatment of opioid use disorder (methadone, buprenorphine, extended-release injection naltrexone) promote abstinence, return patients to healthy functioning, and prevent overdose. Yet most people with opioid use disorder are not getting treatment, and overdose deaths continue to climb. Access to care is part of the problem, along co-occurring mental health problems that complicate care. This symposium will review two major initiatives in New York State to address the opioid treatment gap.
Location
Online
From Date
To Date
Speaker
Qingxian Chen, MS. Qingxian Chen, MS, is the Director the Bureau of Population Health within the Office of Population Health and Evaluation
Molly Finnerty, MD. Dr. Finnerty is the Medical Director and co-lead of the Office of Population Health and Evaluation at NYSOMH, Director of PSYCKES Learning Healthcare Systems, and an Associate Research Professor in Child and Adolescent Psychiatry at New York University
Tim Hunt PhD, MSW, LCSW-r. Dr. Hunt is a research scientist at the Columbia School of Social work, Columbia University School of Social Work, Associate Director with the Social Intervention Group (SIG), the Global Health Research Center of Central Asia (GHRRCA), and Columbia’s Center for Healing of Opioid and Other Substance Use Disorders-Enhancing Intervention, Development and Implementation (CHOSEN)
Molly Finnerty, MD. Dr. Finnerty is the Medical Director and co-lead of the Office of Population Health and Evaluation at NYSOMH, Director of PSYCKES Learning Healthcare Systems, and an Associate Research Professor in Child and Adolescent Psychiatry at New York University
Tim Hunt PhD, MSW, LCSW-r. Dr. Hunt is a research scientist at the Columbia School of Social work, Columbia University School of Social Work, Associate Director with the Social Intervention Group (SIG), the Global Health Research Center of Central Asia (GHRRCA), and Columbia’s Center for Healing of Opioid and Other Substance Use Disorders-Enhancing Intervention, Development and Implementation (CHOSEN)